Sort
30,917 grants matching “tumor microenvironment”
T cell regulation by IDO-competent plasmacytoid dendritic cells
$367,500Andrew Lee Mellor · Augusta University · R01 · FY2010 · AI
Clinical Trials and Translation
$367,442Julie R Park · Children'S Hosp Of Philadelphia · P01 · FY2020 · CA
Homocysteine Stimulates T Cell Activation, Apoptosis and Thymic Involution
$367,439Dennis D. Taub · National Institute On Aging · ZIA · FY2009 · AG
Project 1: Priming and propagating immunity against head and neck cancer using targeted radionuclide therapy
$367,423Zachary Scott Morris · University Of Wisconsin-Madison · P50 · FY2022 · CA
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal
$367,402Joan Siefert Brugge · Whitehead Institute For Biomedical Res · P01 · FY2012 · CA
Immunotherapeutic Modalities for K-ras Mutant Lung Cancer: Sex- and Cell Type-Specific Roles of IL-6/STAT3 signaling
$367,325Seyed Javad Mirhassani Moghaddam · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system
$367,289Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · CA
Regulation of Angpt1 and DIPG blood-brain barrier integrity by H3K27M mutations
$367,240Timothy N Phoenix · University Of Cincinnati · R01 · FY2025 · NS
A Phase I Open Label, Dose Escalation Clinical Trial Assessing the Safety, Tolerability, and Feasibility of pNGVL4aCRTE6E7L2 HPV DNA Vaccine Administration Via Intramuscular TriGridTM Electroporation
$367,205Richard Bruce Roden · Johns Hopkins University · P50 · FY2025 · CA
Integrative approach to identify genomic features that shape the immune landscape and predict immunotherapy response in diffuse large B cell lymphoma
$367,186Justin P. Kline · University Of Chicago · R01 · FY2025 · CA
Integrative approach to identify genomic features that shape the immune landscape and predict immunotherapy response in diffuse large B cell lymphoma
$367,186Justin P. Kline · University Of Chicago · R01 · FY2023 · CA
Targeting Oncogenic KRAS with Brush-Architectured Poly(ethylene glycol)-DNA Conjugates
$367,167Ke Zhang · Northeastern University · R01 · FY2023 · CA
Targeting Oncogenic KRAS with Brush-Architectured Poly(ethylene glycol)-DNA Conjugates
$367,167Ke Zhang · Northeastern University · R01 · FY2022 · CA
CAR NKT Cell Immunotherapy of Neuroblastoma
$367,144Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2024 · CA
CAR NKT Cell Immunotherapy of Neuroblastoma
$367,144Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2023 · CA
CAR NKT Cell Immunotherapy of Neuroblastoma
$367,144Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2021 · CA
CAR NKT Cell Immunotherapy of Neuroblastoma
$367,144Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2025 · CA
Therapeutic resistance and aggressive malignancy in glioblastomas: the contribution of GTP metabolism through regulation by IMPDH2
$367,131Atsuo Sasaki · University Of Cincinnati · R01 · FY2024 · CA
Investigating serum exosomal annexin A2 in promoting aggressive TNBC in African American women
$367,118Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · R01 · FY2021 · CA
Investigating serum exosomal annexin A2 in promoting aggressive TNBC in African American women
$367,118Jamboor K Vishwanatha · University Of North Texas Hlth Sci Ctr · R01 · FY2020 · CA
A PLATFORM TECHNOLOGY TO GENETICALLY REPROGRAM CANCER CELLS FOR ENHANCED IMMUNOTHERAPY
$367,087Stephany Yi Tzeng · Johns Hopkins University · R37 · FY2023 · CA
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
$367,087Drew M. Pardoll · Johns Hopkins University · R01 · FY2023 · CA
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
$367,087Drew M. Pardoll · Johns Hopkins University · R01 · FY2022 · CA
The Tumor Microenvironment in Nanoparticle Delivery and Function
$367,087Zaver M Bhujwalla · Johns Hopkins University · R01 · FY2022 · CA
The Tumor Microenvironment in Nanoparticle Delivery and Function
$367,087Zaver M Bhujwalla · Johns Hopkins University · R01 · FY2023 · CA